Breast cancer biomarker
HER2-low breast cancer: understanding the term and the next treatment questions
HER2-low is more than a label on a test. The pathology report, hormone-receptor status, stage, prior treatment, and disease status need to be read together.
This may be relevant if
- A pathology report uses the term HER2-low or low HER2 expression.
- You want to understand the testing and options that may be discussed.
- Breast cancer is advanced, recurrent, or progressing after treatment.
What information matters?
Start with what you have. Missing information can be marked and completed later.
- HER2 score or result from the pathology report
- ER, PR, and related testing
- Stage and disease sites
- Previous treatments and response
A practical next step
- 1Save the pathology report and HER2 result in the Cancer Passport.
- 2Record sections that are unclear or need confirmation.
- 3Request a review to discuss treatment sequence and potentially relevant access options.
Not a diagnosis and not final medical advice. Must be reviewed by a doctor.
Review your HER2-low context
Bring pathology, biomarkers, and treatment history together so questions for a doctor or navigator are more focused.
After submission, a human navigator reviews your request and contacts you through your chosen channel. The WhatsApp message already includes this page context, so you do not need to explain from the beginning.
Clinical data is not requested in the form and is not sent to analytics. Do not send medical reports through WhatsApp or email; use the secure upload page. We do not promise eligibility or any treatment outcome.
Continue exploring
Use a case summary, not a copied medical history
The Cancer Passport keeps the information you choose to save in one place so a later review can start from the same context.
Ready to take the next step?
Start with the information you have. A navigator can help identify what to review next.
Prepare for your next consultation
Use the free six-question tool to prepare questions for your doctor.